NASDAQ:GLMD

Galmed Pharmaceuticals - GLMD Price Target & Analyst Ratings

$0.45

+0.02 (+4.65%)

(As of 03/29/2023 12:00 AM ET)

Add

Compare

Today's Range: $0.37
▼
$0.45
50-Day Range: $0.40
▼
$0.75
52-Week Range: $0.29
▼
$1.84

Volume: 118,932 shs
Average Volume: 27,684 shs
Market Capitalization: $11.29 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $5.00

Institutional Ownership

Galmed Pharmaceuticals Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 5 Analyst Ratings

Consensus Analyst Price Target

$5.00
1,011.11% Upside

High Prediction	$5.00
Average Prediction	$5.00
Low Prediction	$5.00

Type	Current 3/30/22 to 3/30/23	1 Month Ago 2/28/22 to 2/28/23	3 Months Ago 12/30/21 to 12/30/22	1 Year Ago 3/30/21 to 3/30/22
Consensus Rating	Hold	Hold	Hold	N/A
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	N/A
Buy	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)	N/A
Hold	5 Hold rating(s)	5 Hold rating(s)	5 Hold rating(s)	N/A
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	N/A
Consensus Price Target	$5.00	$5.00	$5.00	N/A
Predicted Upside	1,011.11% Upside	447.05% Upside	447.05% Upside	N/A

Get Galmed Pharmaceuticals Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for GLMD and its competitors with MarketBeat's FREE daily newsletter.

GLMD Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

GLMD Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Galmed Pharmaceuticals Stock vs. The Competition

Type	Galmed Pharmaceuticals	Medical Companies	S&P 500
Consensus Rating Score	2.00	2.64	2.47
Consensus Rating	Hold	Buy	Hold
Predicted Upside	1,011.11% Upside	1,938.44% Upside	200.53% Upside
News Sentiment Rating	Neutral News	Positive News	Positive News

Historical Target Prices and Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
8/8/2022	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold
8/8/2022	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold
8/4/2022	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Kluska Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Neutral
5/18/2022	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform
5/3/2022	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Arce Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral
7/12/2020	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Market Perform	$33.00	+626.87%
5/22/2020	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Mamtani Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$11.00 ➝ $8.00	+36.52%

(Data available from 3/30/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

GLMD Price Target - Frequently Asked Questions

What is Galmed Pharmaceuticals's consensus rating and price target?: According to the issued ratings of 5 analysts in the last year, the consensus rating for Galmed Pharmaceuticals stock is Hold based on the current 5 hold ratings for GLMD. The average twelve-month price prediction for Galmed Pharmaceuticals is $5.00 with a high price target of $5.00 and a low price target of $5.00. Learn more on GLMD's analyst rating history.
Do Wall Street analysts like Galmed Pharmaceuticals more than its competitors?: Analysts like Galmed Pharmaceuticals less than other Medical companies. The consensus rating for Galmed Pharmaceuticals is Hold while the average consensus rating for medical companies is Buy. Learn more on how GLMD compares to other companies.
Does Galmed Pharmaceuticals's stock price have much upside?: According to analysts, Galmed Pharmaceuticals's stock has a predicted upside of 447.05% based on their 12-month price targets.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

This page (NASDAQ:GLMD) was last updated on 3/30/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial